Does the MTRR rs1801394 GG genotype increase risk of functional vitamin B12 deficiency?

The MTRR rs1801394 GG genotype plays a significant role in the regulation of one-carbon metabolism, specifically influencing the efficiency of the methionine cycle and the recycling of vitamin B12.

Clinical and metabolic evidence

Research consistently identifies the MTRR rs1801394 GG genotype as a factor in altered vitamin B12-dependent processes.

• Homocysteine Levels: Individuals with the GG genotype often exhibit modestly higher plasma homocysteine levels compared to those with the AA genotype. This elevation is particularly pronounced when vitamin B12 or folate levels are in the lower quartiles of the reference range.
• Methylation Capacity: The GG variant is associated with reduced levels of S-adenosylmethionine (SAM), the body's primary methyl donor. This reduction can lead to altered DNA methylation patterns, which are observed in clinical studies focusing on developmental risks and cardiovascular health.
• Synergistic Effects: The metabolic impact of the GG genotype is often compounded by other genetic variants, such as MTHFR 677TT, creating a greater risk for hyperhomocysteinemia than either variant alone.

Mechanistic explanations

The MTRR gene encodes methionine synthase reductase, an enzyme critical for the "re-activation" of vitamin B12 within the methionine cycle.

• Enzyme Substitution: The rs1801394 G allele causes an isoleucine-to-methionine substitution (I22M) within the FMN-binding domain of the enzyme. This change significantly reduces the efficiency with which MTRR transfers electrons to regenerate active methylcobalamin.
• The B12 Bottleneck: Methionine synthase (MTR) requires methylcobalamin to convert homocysteine into methionine. When MTRR activity is low, the cobalamin cofactor remains in an oxidized, inactive state, effectively "trapping" the vitamin and preventing it from facilitating remethylation.
• Functional Deficiency: This mechanism explains "functional" B12 deficiency, where cellular utilization is impaired despite having serum B12 levels that appear clinically normal.

Bottom line

The MTRR rs1801394 GG genotype is a well-supported risk factor for impaired B12-dependent methylation and elevated homocysteine. Its primary health implication is a heightened vulnerability to functional B12 deficiency, suggesting that carriers may require higher-than-average B12 levels to maintain optimal metabolic function.